Cargando…

Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic

Many healthcare systems rapidly implemented telehealth as a substitute for in-person care during the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this review is to describe the evidence base supporting the use of telehealth for chronic obstructive pulmonary disease (COPD) prior to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sculley, Jennifer A., Musick, Hugh, Krishnan, Jerry A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	OBSTRUCTIVE, OCCUPATIONAL AND ENVIRONMENTAL DISEASES: Edited by Manish Joshi and Basil Varkey
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815630/ https://www.ncbi.nlm.nih.gov/pubmed/34860202 http://dx.doi.org/10.1097/MCP.0000000000000851

Ejemplares similares

Chronic obstructive pulmonary disease and COVID-19: interrelationships
por: Singh, Dave, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
por: Wang, Jennifer M., et al.
Publicado: (2022)

IMPACT OF INHALED CORTICOSTEROID USE ON OUTCOMES IN HOSPITALIZED PATIENTS WITH COVID-19 AND OBSTRUCTIVE LUNG DISEASES
por: MARLIERE, MANUEL HACHE, et al.
Publicado: (2022)

HYPERSENSITIVITY PNEUMONITIS PRESENTING AS SEVERE CYSTIC LUNG DISEASE FOLLOWING COVID-19 INFECTION
por: YADAV, HARIKA, et al.
Publicado: (2022)

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease
por: Hodgson, Shane, et al.
Publicado: (2017)

Comorbidities and mortality among patients with chronic obstructive pulmonary disease
por: Skajaa, Nils, et al.
Publicado: (2023)

Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
por: Li, Min, et al.
Publicado: (2023)

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
por: Polosukhin, Vasiliy V, et al.
Publicado: (2021)

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
por: Dorresteijn, Johannes A N, et al.
Publicado: (2013)

Gene expression profiling in persons with multiple chemical sensitivity before and after a controlled n-butanol exposure session
por: Dantoft, Thomas M, et al.
Publicado: (2017)

Use, utility and methods of telehealth for patients with COPD in England and Wales: a healthcare provider survey
por: Al Rajeh, Ahmed, et al.
Publicado: (2019)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Productivity losses in chronic obstructive pulmonary disease: a population-based survey
por: Erdal, Marta, et al.
Publicado: (2014)

Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
por: Santer, Peter, et al.
Publicado: (2020)

Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease
por: Annangi, Srinadh, et al.
Publicado: (2022)

How does work disability of patients with MS develop before and after diagnosis? A nationwide cohort study with a reference group
por: Gyllensten, Hanna, et al.
Publicado: (2016)

Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD)
por: Arbillaga-Etxarri, Ane, et al.
Publicado: (2017)

Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease
por: Nishimura, Koichi, et al.
Publicado: (2018)

Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
por: Kusunose, Masaaki, et al.
Publicado: (2017)

Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Hitchings, Andrew W, et al.
Publicado: (2016)

Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease
por: Hall, James, et al.
Publicado: (2022)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
por: Han, Meilan K, et al.
Publicado: (2020)

Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
por: Vilarinho, Rui, et al.
Publicado: (2022)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Characteristics of inflammatory phenotypes in patients with chronic obstructive pulmonary disease: a cross-sectional study
por: Wen, Xiang, et al.
Publicado: (2023)

Sex-specific and age-specific incidence of ischaemic heart disease, atrial fibrillation and heart failure in community patients with chronic obstructive pulmonary disease
por: Groenewegen, Amy, et al.
Publicado: (2022)

Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease
por: Savage, Charlotte Claire, et al.
Publicado: (2018)

Evaluation of ‘care bundles’ for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK
por: Morton, Katherine, et al.
Publicado: (2019)

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

The physiology of singing and implications for ‘Singing for Lung Health’ as a therapy for individuals with chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2021)

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
por: Pavey, Holly, et al.
Publicado: (2023)

Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study
por: Zhu, Zheng, et al.
Publicado: (2023)

Assessment of lung hyperinflation in occupational chronic obstructive pulmonary disease: a multicentric cross-sectional study
por: de Broucker, Virginie, et al.
Publicado: (2023)

Trends in occupational diseases in Finland, 1975–2013: a register study
por: Oksa, Panu, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis
por: Sana, Adama, et al.
Publicado: (2018)

Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease
por: Le, Tham Thi, et al.
Publicado: (2020)

Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease—health care utilisation in the subsequent 2 years
por: Walsh, James R, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9o54g7vnernfds2acpkl228jd5